Welcome Guest | Register / Login

Pharmaceuticals Market Research Reports

The global pharmaceutical market has persistently experienced significant growth due to the ever-increasing demand for novel and more effective drugs. The reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth, newer and more complex disease conditions, ageing population, and the increased prevalence of chronic and infectious diseases, some of which still remain incurable and fatal. Such numerous unmet needs and high demand rates have triggered the boost in R&D investments by key industry sectors, greatly driving the growth of this i... View more

Sort By
Title Published Price Buy Now
China Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: China will become a leading medical research hub within the Asia Pacific region. This will be largely led by multinational pharmaceutical firms as they seek to tap the large talent pool within the country and develop treatments ...
Jul 2016 $ 1295
Botswana Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Multinational drugmaker presence in Botswana will be limited to imports as the small market size and lack of investment incentives deter any large-scale investment plans. Although generic drugs will retain their dominance in ter...
Jul 2016 $ 1295
Zambia Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: The Zambian government will continue to boost social expenditure as President Lungu attempts to gain public favour in light of the August general elections. Fiscal revenues will increase gradually, in line with the copper sector...
Jul 2016 $ 1295
Vietnam Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Leveraging Vietnam's National Expanded Immunisation Programme (EPI) will be of strategic benefit to multinational pharmaceutical firms with a strong vaccines portfolio. Government support for the initiative is expected to remain...
Jul 2016 $ 1295
Virbac: Strategic Direction, Marketing Tactics and Technological Know-How in the Global Animal Health Market
By Venture Planning Group
Strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, the task crucial to business survival, growth and profitability.This new report from VPGMarketResearch.com pro...
Jul 2016 $ 750
Zoetis: Strategic Direction, Marketing Tactics and Technological Know-How in the Global Animal Health Market
By Venture Planning Group
Strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, the task crucial to business survival, growth and profitability.This new report from VPGMarketResearch.com pro...
Jul 2016 $ 750
Phibro: Strategic Direction, Marketing Tactics and Technological Know-How in the Global Animal Health Market
By Venture Planning Group
Strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, the task crucial to business survival, growth and profitability.This new report from VPGMarketResearch.com pro...
Jul 2016 $ 750
Merck: Strategic Direction, Marketing Tactics and Technological Know-How in the Global Animal Health Market
By Venture Planning Group
Strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, the task crucial to business survival, growth and profitability.This new report from VPGMarketResearch.com pro...
Jul 2016 $ 750
Elanco: Strategic Direction, Marketing Tactics and Technological Know-How in the Global Animal Health Market
By Venture Planning Group
Strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, the task crucial to business survival, growth and profitability.This new report from VPGMarketResearch.com pro...
Jul 2016 $ 750
Ceva: Strategic Direction, Marketing Tactics and Technological Know-How in the Global Animal Health Market
By Venture Planning Group
Strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, the task crucial to business survival, growth and profitability.This new report from VPGMarketResearch.com pro...
Jul 2016 $ 750
Bayer: Strategic Direction, Marketing Tactics and Technological Know-How in the Global Animal Health Market
By Venture Planning Group
Strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, the task crucial to business survival, growth and profitability.This new report from VPGMarketResearch.com pro...
Jul 2016 $ 750
Uzbekistan Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Uzbekistan's pharmaceutical market represents an underdeveloped and potentially lucrative market for multinational drugmakers. Firms based within the CIS States are well positioned to take advantage of this potential given the c...
Jul 2016 $ 1295
United Kingdom Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: The rate of investment in pharmaceutical and biomedicine R&D in the UK will remain significantly high. Meanwhile, our earlier view on upside risks to healthcare spending has started to materialise, with the latest data leading u...
Jul 2016 $ 1295
Ukraine Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Wide-scale changes to the regulatory environment of Ukraine's pharmaceutical sector will increase its attractiveness to multinational pharmaceutical manufactures. The introduction of reference pricing will aid in improving medic...
Jul 2016 $ 1295
Taiwan Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Cross-strait relations will be an important factor influencing the prospects of Taiwan's pharmaceutical industry. The country's medicine exports to China have grown substantially and now account for 14% of the total value, ahead...
Jul 2016 $ 1295
Poland Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Poland will remain one of the most attractive pharmaceutical and healthcare markets in the CEE region. Strong economic growth and the introduction of a tax-funded healthcare system will support strong market growth. Opportunitie...
Jul 2016 $ 1295
Philippines Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: The Philippine pharmaceutical market is relatively small considering its large population and disease burden. Low government spending on healthcare, which falls below the WHO's global standards, and low-income levels limit oppor...
Jul 2016 $ 1295
Netherlands Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: The Netherlands has a well establish pharmaceutical and healthcare sector. In 2016, the pharmaceutical market will face yet another year of contraction in value terms before returning to growth in 2017. Medicine sales will be dr...
Jul 2016 $ 1295
Mozambique Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Mozambique has a high-risk low-reward pharmaceutical market, which suffers from poor regulation, low per-capita spending and a high abundance of counterfeit medicines in circulation. Further, ongoing political violence and lack ...
Jul 2016 $ 1295
Mexico Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: The government's efforts to improve competitiveness in Mexico's pharmaceutical sector combined with the country's economic outperformance compared with large countries like Brazil will improve Mexico's attractiveness to drugmake...
Jul 2016 $ 1295
Israel Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Israel will continue to be targeted by multinational drugmakers as a destination for innovative drug sales; however, their relative success will be limited by funding constraints towards the country's health services basket and ...
Jul 2016 $ 1295
Iran Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: The Iranian government is looking to attract greater direct investment by leveraging the growing interest of multinational pharmaceutical companies interested in exploring the high-growth potential of Iran's pharmaceutical marke...
Jul 2016 $ 1295
Global Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Pharmaceutical companies will face an increasing number of external risks to their operations. Many of these new challenges emanate from the global financial crisis of 2007/08. In an era of fiscal pressures, governments are seek...
Jul 2016 $ 1295
Europe Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Europe will remain the most attractive region for multinational pharmaceutical firms over the coming years. The Western European region is defined by highly developed markets with significant demand for both patented and generic...
Jul 2016 $ 1295
Asia Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Asia is a key growth opportunity for pharmaceutical firms. The sector's growth is supported by a solid economic foundation, projected to outperform with an average real GDP growth of 5% as compared to 3% globally over the next f...
Jul 2016 $ 1295